Full Text View
Tabular View
No Study Results Posted
Related Studies
Bad Breath Response to Tongue Scraper and Rinses
This study is enrolling participants by invitation only.
First Received: March 20, 2009   No Changes Posted
Sponsored by: University of California, San Francisco
Information provided by: University of California, San Francisco
ClinicalTrials.gov Identifier: NCT00867035
  Purpose

Medical center personnel are screened organoleptically for bad breath by 2 investigators using Rosenberg scale 0-5, and measurement of breath sample in gas chromatograph. With a threshold score of 2 or more, or 75ppb H2S, subjects invited to enter clinical trial of the mechanical effect of daily tongue scraping with the adjunctive use of 0.12% chlorhexidine gluconate mouthwash or 0.1% stabilized chlorine dioxide. Subjects randomly assigned in double-blind trial for one week. The null hypothesis is there will be no difference between the two rinses as adjuncts to tongue scraping.


Condition Intervention
Halitosis
Drug: stabilized chlorine dioxide mouthwash
Drug: chlorhexidine gluconate

Drug Information available for: Chlorhexidine Chlorides Chlorhexidine digluconate Hibiclens Gluconic acid D-Gluconic acid, monosodium salt Manganese gluconate
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Active Control, Parallel Assignment, Bio-equivalence Study
Official Title: Bad Breath Response to Tongue Scraper and Rinses

Further study details as provided by University of California, San Francisco:

Primary Outcome Measures:
  • organoleptic score [ Time Frame: one week ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • concentration of volatile sulfur compounds in mouth air [ Time Frame: one week ] [ Designated as safety issue: No ]

Estimated Enrollment: 50
Study Start Date: July 2008
Estimated Study Completion Date: July 2009
Estimated Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Drug. tongue scraper and 20ml of 0.1% chlorine dioxide mouthwash used for 30sec twice a day
Drug: stabilized chlorine dioxide mouthwash
20ml of 0.1% stabilized chlorine dioxide mouthwash used for 30sec as adjunct to tongue scraper twice a day
2: Active Comparator
Drug. tongue scraper and 20ml of 0.12% chlorhexidine gluconate mouthwash used for 30 sec twice a day
Drug: chlorhexidine gluconate
20ml of 0.12% chlorhexidine gluconate used for 30 sec as mouthwash adjunct to tongue scraper of one week.

Detailed Description:

Subjects in trial will have oral and periodontal exam and score the Ramfjord teeth for PlI, GI, PD, recession. A tongue index is scored and sample of coating on dorsum taken for culture of total viable count and % black colonies on anaerobe agar with sulfur added. Subjects given hygiene instruction and instruction on use of scraper, then rinse with 20ml assigned mouthwash 30sec. Breath assessed by organoleptic means and mouth air sample in chromatograph at 0, 1, 2, and 4 hours. Subjects use scraper and mouthwash twice daily for one week and return for final exam.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Adult with threshold score of 2 on organoleptic halitosis evaluation

Exclusion Criteria:

  • Taking another experimental drug, or antibiotic.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00867035

Locations
United States, California
UCaliforniaSF
San Francisco, California, United States, 94143
Sponsors and Collaborators
University of California, San Francisco
Investigators
Principal Investigator: Milton R Wirthlin, DDS University of California, San Francisco
  More Information

No publications provided

Responsible Party: Department of Orofacial Sciences, UCSF ( Milton Robert Wirthlin, DDS, MS )
Study ID Numbers: PGP1
Study First Received: March 20, 2009
Last Updated: March 20, 2009
ClinicalTrials.gov Identifier: NCT00867035     History of Changes
Health Authority: United States: Institutional Review Board

Study placed in the following topic categories:
Anti-Infective Agents, Local
Chlorine dioxide
Signs and Symptoms
Disinfectants
Chlorhexidine
Signs and Symptoms, Digestive
Chlorhexidine gluconate
Halitosis

Additional relevant MeSH terms:
Anti-Infective Agents
Chlorhexidine
Signs and Symptoms, Digestive
Dental Disinfectants
Pharmacologic Actions
Signs and Symptoms
Chlorine dioxide
Anti-Infective Agents, Local
Disinfectants
Chlorhexidine gluconate
Therapeutic Uses
Halitosis
Dermatologic Agents

ClinicalTrials.gov processed this record on May 07, 2009